John Treace Insider Trades & Stock Holdings

Chief Executive Officer · Treace Medical Concepts, Inc. · Latest filing Jun 11, 2026

John Treace, Chief Executive Officer at Treace Medical Concepts, Inc. has 1 Form 4 trade on file since Jun 11, 2026. Open-market activity: 1 purchase ($39.96K) and 0 sales ($0), net +$39.96K. Latest filing: acquired 9.89K shares of $TMCI on Jun 11, 2026 at $4.04.

Trades on file

1

Open-market bought

$39.96K

Open-market sold

$0

Net open-market

+$39.96K

Latest filing

Jun 11, 2026

All insider trades by John Treace

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 11, 2026	$TMCI	Buy (Open-market buy)	9.89K	$4.04	$39.96K						Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks John Treace traded

• $TMCI

Frequently asked questions

Has John Treace been buying or selling stock?

John Treace has 1 open-market purchase and 0 open-market sales on file, net +$39.96K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was John Treace's latest insider trade?

acquired 9.89K shares of $TMCI on Jun 11, 2026 at $4.04.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.